"10.1371_journal.pone.0113937","plos one","2014-12-12T00:00:00Z","Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals","Merck & Co. Inc., Department of Genetics and Pharmacogenomics, Boston, Massachusetts, United States of America; Merck & Co. Inc., Department of Biometrics Research, Whitehouse Station, New Jersey, United States of America; Spire Sciences Inc., Boca Raton, Florida, United States of America; Virtual Scopics, Rochester, New York, United States of America; Merck & Co. Inc., Clinical Research, Whitehouse Station, New Jersey, United States of America","Conceived and designed the experiments: KM JK AL CB. Performed the experiments: KM JK. Analyzed the data: KM RB JK AL CP JD JR CB. Wrote the paper: KM RB JK AL CP JD JR CB.","The authors of this manuscript have the following competing interests: K. MacIsaac, J. Kang, A. Loboda, C. Beals, R. Baumgartner, are currently (or were at the time the study was conducted) employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, who may own stock and/or hold stock options in Merck. C. Peterfy and J. DiCarlo are employees of Spire Sciences LLC, employed by the study sponsor Merck to analyze study results; J. Riek is an employee of VirtualScopics, Inc, employed by the study sponsor Merck to analyze study results. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","12","Kenzie D MacIsaac","KDMI",8,TRUE,4,2,8,8,TRUE,TRUE,FALSE,0,NA,FALSE
